Did the Addition of Concomitant Chemotherapy to Radiotherapy Improve Outcomes in Hypopharyngeal Cancer? A Population-Based Study | Zendy

Stephen F. Hall | Zendy; Rebecca Griffiths | Zendy

Open Access

Did the Addition of Concomitant Chemotherapy to Radiotherapy Improve Outcomes in Hypopharyngeal Cancer? A Population-Based Study

Author(s) -

Stephen F. Hall,

Rebecca Griffiths

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.3085

Subject(s) - medicine , radiation therapy , head and neck cancer , hypopharyngeal cancer , concomitant , incidence (geometry) , population , head and neck , oncology , cancer , retrospective cohort study , cohort , surgery , environmental health , physics , optics

For oncologists and for patients, no site-specific clinical trial evidence has emerged for the use of concurrent chemotherapy with radiotherapy (ccrt) over radiotherapy (rt) alone for cancer of the hypopharynx (hpc) or for other human papilloma virus-negative head-and-neck cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research